.Avidity Biosciences amazed investors with phase 1/2 data in Duchenne muscle dystrophy (DMD) Friday,...
.Actinogen Medical's cortisol blocker has actually missed out on the major endpoint of a stage 2 res...
.Antibody-drug conjugates (ADCs) have gone to the center of several a billion-dollar biobuck licensi...
.Resource supervisor TPG, which has assisted biotechs such as Sionna Rehabs as well as Santa Ana Bio...
.Merck & Co.'s TIGIT program has endured another setback. Months after shuttering a phase 3 melan...
.After a year defined by pipeline cuts, the departure of its CEO and also discharges, Exscientia is ...
.Cullinan Therapeutics was actually thrilled sufficient along with Port BioMed's bispecific immune a...
.In this particular full week's incident of "The Best Line," our experts are actually diving into Br...
.The confetti is still soaring coming from Eli Lilly's party commemorating the commendation of Alzhe...
.Invite to today's Chutes & Ladders, our roundup of significant management hirings, shootings and...